Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Patanjali Ayurved Ramdev
Where does the buck stop after SC rap on Patanjali? Can Blinkit challenge Amazon & Flipkart? Why did Vodafone Idea's fundraise plan fail? What is the Carbon Border Adjustment Mechanism? Answers here
Nepal's drug regulatory authority has blacklisted 16 Indian pharmaceutical companies, including Divya Pharmacy which manufactures Yoga Guru Ramdev's Patanjali products, stating that they failed to comply with the World Health Organisation's (WHO) drug manufacturing standards. The Department of Drug Administration, in a notice issued on December 18 asked the local agents in Nepal, which have been supplying these medicines, to immediately recall them. According to the notice issued by the Department, the medicines manufactured by the listed companies cannot be imported or distributed in Nepal. The list of the companies that do not comply with WHO standards were published after inspection of the manufacturing facilities of the pharmaceutical companies that had applied to export their products to Nepal, according to the Department officials. In April and July, the Department sent a team of drug inspectors to India to inspect the manufacturing facilities of pharmaceutical companies that
The Delhi High Court will hear on Monday a plea by seven doctors' associations against Yoga guru Ramdev for allegedly spreading misinformation by his statements against allopathy amid the ongoing COVID-19 pandemic. The matter will be heard by Justice C Hari Shankar who had earlier asked the counsel for the associations to place on record the videos pertaining to the alleged misinformation. The associations before court are three Resident Doctors' Association of the All India Institute of Medical Sciences at Rishikesh, Patna and Bhubaneshwar, Association of Resident Doctors, Post Graduate Institute of Medical Education & Research, Chandigarh, Union of Resident Doctors of Punjab (URDP); Resident Doctors' Association, Lala Lajpat Rai Memorial Medical College, Meerut and Telangana Junior Doctors' Association, Hyderabad. They alleged that Ramdev was misleading and misrepresenting to the public at large that allopathy was responsible for the deaths of several people infected by ...
Baba Ramdev-led Patanjali Ayurved on Tuesday said it has raised Rs 175 crore by issuing non-convertible debentures (NCDs).
Business Standard brings you the top headlines of the day
On June 23, Baba Ramdev-led Patanjali Ayurved launched a medicine, 'Coronil', for treating Covid-19 in just seven days
From Rs 16.9 to Rs 1,519 in five months, the stock has seen a spectacular rise of 8,988 per cent
Haridwar-based Patanjali Ayurved on Tuesday launched "Coronil", claiming it can cure COVID-19
India death toll crosses 15,000; Maharashtra, Delhi, Tamil Nadu account for 68% of cases added today
The Haridwar-based company on Tuesday launched "Coronil", claiming it can cure Covid-19
The total number of Covid-19 cases in Delhi crossed the 66,000 mark, with the biggest single-day spike of 3,947 fresh infections being reported on Tuesday
The Ministry had also issued a notification in April stating the requirements and the manner in which the research studies on Covid-19 with AYUSH interventions/medicines should be undertaken
Hours after the launch, the ministry denied knowledge of the drugs and asked the group to refrain from publicising them.
According to government data, the situation in India is not as alarming as some of the other countries, given a limited spread on a per-capita basis
The edible oil maker's market capitalisation is up nearly 300 times since the beginning of November last year and 70 times since its acquisition by Pantanjali Ayurved under the IBC
The fund-raising will be used to meet the Haridwar-based company's working capital requirements and strengthen the supply chain network
Food park will come up over 91 acres near Yamuna Expressway
The company had reported a revenue of Rs 937 crore and Rs 1,576 crore in June quarter and September quarter of 2018-19, respectively.
Care Ratings Ltd. downgraded Patanjali's long-term bank facilities to A- from A+, according to a statement on Friday
According to a recent IIFL report, sales of Patanjali products have halved from two year earlier levels.